• SENSEX 82,500.47
    -689.81 (--0.83%)
  • BANKNIFTY 56,754.70
    -201.30 (--0.35%)
  • Enviro Infra
    284.00 392.00(%)
  • Mamata Machinery
    525.00 649.00(%)
  • Glenmark Pharma.
    2,286.15 2,286.15(%)
  • Crizac
    364.00 364.00(%)
  • TCS
    3,261.35 3,060.25(%)
  • Eternal Ltd
    264.90 304.50(%)
  • Hind. Unilever
    2,530.00 3,034.50(%)
  • JP Power Ven.
    24.86 24.86(%)
  • Indian Renewable
    159.05 137.00(%)
  • Tata Elxsi
    5,679.00 4,601.05(%)
  • Infosys
    1,563.25 1,307.10(%)
  • Netweb Technol.
    1,989.00 3,060.00(%)
  • Reliance Industr
    1,490.10 1,115.55(%)
  • RattanIndia Pow.
    15.90 8.44(%)
  • Meta Infotech
    236.25 236.25(%)
  • Interglobe Aviat
    5,937.00 6,019.20(%)
  • Quality Power El
    760.90 270.60(%)
  • Bharat Electron
    404.95 240.15(%)
  • ICICI Bank
    1,414.55 1,153.30(%)
  • Kirloskar Oil
    895.60 544.15(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Unjha Formulations Ltd Pharmaceuticals - Indian - Formulations

  • Indian Private
  • BSE Code : 7112.0
  • ISIN : INE576D01015
23.50 0 (1.95%)
  • As on 12 Jul 2025 (EOD)
  • Today’s Low

    23.50
  • Today’s High

    23.64
  • Open

    23.64
  • Perv Close

    23.05
  • 52W Low

    19.99
  • 52W High

    39.00

Key Indicators

  • P/E(TTM)

    25.82

  • Mar.Cap (₹Cr.)

    10.53

  • Div & Yield %

    0.00

  • Book Value(₹)

    7.01

  • Debt-Equity Ratio

    1.95

  • AGM Date

    11-Jul-2025

  • EPS

    0.91

  • P/E Ratio

    25.82

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    10.53

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    4.48

  • BV (₹)

    7.00

  • Sales( ₹ in Cr.)

    13.86

  • NP (in Cr.)

    0.41

  • NP Var(%)

    47.0

  • Div%

    0.0

  • CPS (₹)

    1.10

  • EPS (₹)

    0.90

  • Traded Value (₹ in Lakhs)

    10.53

  • 52 Week High

    39.00

  • 52 Week Low

    19.99

  • Price BSE

    24.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    10.53

  • P/C Ratio

    21.30

  • P/E Ratio

    26.40

  • Price Vs.BV

    0.90

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 18.50 13.15 14.16 9.96 10.60 11.42
Excise Duty 0.00 0.00 0.00 0.00 0.00 0.00
Net Sales 18.50 13.15 14.16 9.96 10.60 11.42
Other Income 0.01 0.03 0.19 0.22 0.26 0.10
Stock Adjustments 0.22 -0.08 0.24 0.12 -0.34 -0.15
Total Income 18.73 13.10 14.59 10.30 10.52 11.37
EXPENDITURE :            
Raw Materials 15.78 10.61 11.70 7.67 7.86 8.61
Power and Fuel Cost 0.07 0.06 0.06 0.06 0.07 0.07
Employee Cost 0.59 0.51 0.56 0.48 0.44 0.42
Other Manufacturing Expenses 0.89 0.76 1.12 0.92 0.97 0.83
Selling and Administration Expenses 0.82 0.69 0.56 0.72 0.56 0.72
Miscellaneous Expenses 0.00 0.00 0.07 0.08 0.10 0.32
Employee Benefit Expenses 0.59 0.51 0.56 0.48 0.44 0.42
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 18.15 12.64 14.08 9.93 10.01 10.98
Operating Profit 0.58 0.47 0.51 0.35 0.51 0.40
Interest 0.05 0.06 0.13 0.17 0.12 0.01
Gross Profit 0.53 0.41 0.38 0.18 0.39 0.39
Depreciation 0.08 0.08 0.08 0.08 0.08 0.09
Profit Before Tax 0.45 0.33 0.30 0.10 0.31 0.30
Current Tax 0.17 0.05 0.05 0.00 0.00 0.00
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.01 0.00 0.00 0.00 0.00 0.00
Reported Net Profit 0.28 0.28 0.25 0.10 0.31 0.30
Extraordinary Items 0.00 0.00 0.00 0.00 0.00 0.00
Adjusted Net Profit 0.28 0.28 0.25 0.10 0.31 0.30
Adjustment below Net Profit 0.00 0.00 -2.76 -2.86 -3.17 -3.47
P & L Balance brought forward -2.22 -2.50 0.00 0.00 0.00 0.00
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance carried down -1.94 -2.22 -2.50 -2.76 -2.86 -3.17
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Per Share-Unit Curr 0.62 0.63 0.56 0.23 0.69 0.67
Earnings Per Share(Adj)-Unit Curr 0.62 0.63 0.56 0.23 0.69 0.67
Book Value 6.10 5.48 4.84 4.28 4.05 3.36
Book Value(Adj)-Unit Curr 6.10 5.48 4.84 4.28 4.05 3.36

Shareholding Pattern

  • Promoter Group

    36.93%

  • Public Share Holding

    63.08%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 0 0.00 0 0
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 1,654,424 36.93 1,654,424 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 1,654,424 36.93 1,654,424 4
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 47,553 1.06 44,253 22
Clearing Members 0 0.00 0 0
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 18,179 0.41 14,979 22
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 522,244 11.66 522,244 12
Individuals holding nominal share capital up to Rs. 1 lakh 1,991,317 44.44 1,482,317 4,101
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 246,783 5.51 246,783 52
Sub Total 2,826,076 63.08 2,310,576 4,209
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 4,480,500 100.00 3,965,000 4,213

Company Background

Unjha Formulations LtdPharmaceuticals - Indian - Formulations

  • Unjha Formulations Ltd
  • BSE Code : 7112.0
  • ISIN : INE576D01015
  • Incorporation Year

    1994

  • Registered Office

    Khali Char Rasta
    State Highway Ta Sidhpur, Patan,
    Gujarat-384151

  • Telephone

    91-2767-282395

  • FAX

    91-2767-282396

  • Chairman

    Jashodaben S Patel

  • Managing Director

    Krutiben M Patel

  • Company Secretary

    Jigar Ray

  • Auditor

    Jain & Golechha/Milind Shah & Co

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    MUFG Intime Pvt Ltd
    5th Floor 506 to 508,
    ABC-I Off C G Road,Navrangpura
    Mumbai - Ahmedabad-380009

Unjha Formulations Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Unjha Formul. 23.50 18.51 18.50 25.82 10.71
Abbott India 34,409.95 6,097.18 5,848.91 51.70 44.71
Astrazeneca Phar 9,237.05 1,330.33 1,295.53 199.50 33.26
P & G Health Ltd 5,777.05 1,166.89 1,151.26 38.18 39.76
Glaxosmi. Pharma 3,242.30 3,866.05 3,723.49 59.77 58.72
Cipla 1,485.05 20,029.57 19,044.85 23.25 21.40
Amrutanjan Healt 726.25 437.58 421.23 41.31 20.84
Fermenta Biotec. 384.45 315.24 307.09 16.74 4.10
Guj. Themis Bio. 343.55 174.19 169.82 76.69 44.82
Bliss GVS Pharma 153.75 703.42 667.20 23.51 9.16
Ambalal Sarabhai 36.16 19.33 4.04 33.48 2.10